Effects of Optimized Antiplatelet Treatment After Percutaneous Coronary Intervention
Status:
Completed
Trial end date:
2007-06-01
Target enrollment:
Participant gender:
Summary
Effects of dual antiplatelet therapy with aspirin and clopidogrel after percutaneous coronary
intervention has been proven. However, patients with low response to those agents are
reported be associated with adverse clinical outcomes. We suppose that optimized antiplatelet
therapy for individual patients based on platelet function assay may improve long-term
outcomes especially in patients with high risk of thrombosis. In this prospective randomized
study, patients in control group all receive standard dual antiplatelet therapy, and patients
in optimized group receive different antiplatelet therapy according to risk stratification.